Cantex Pharmaceuticals
Juan F. Rodriguez has served as the Chief Financial Officer since November 2014, bringing more than 20 years of financial and business leadership experience to Cantex, the majority of which has been in the life sciences field. Prior to joining Cantex, Juan Rodriquez was the CFO of OPKO Health, Inc (NASDAQ:OPK) and, prior to that Senior Vice President and Controller at Kos Pharmaceuticals, acquired by Abbott for $3.7B.
This person is not in any offices
Cantex Pharmaceuticals
Cantex Pharmaceuticals, Inc. is a pharmaceutical company developing treatments of cancer, complications of COVID-19 infection, and pulmonary inflammatory diseases.